These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30552041)

  • 1. Effects of nicotine and atomoxetine on brain function during response inhibition.
    Kasparbauer AM; Petrovsky N; Schmidt PM; Trautner P; Weber B; Sträter B; Ettinger U
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):235-246. PubMed ID: 30552041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving response inhibition in Parkinson's disease with atomoxetine.
    Ye Z; Altena E; Nombela C; Housden CR; Maxwell H; Rittman T; Huddleston C; Rae CL; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
    Biol Psychiatry; 2015 Apr; 77(8):740-8. PubMed ID: 24655598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenaline transporter blockade increases fronto-parietal functional connectivity relevant for working memory.
    Hernaus D; Casales Santa MM; Offermann JS; Van Amelsvoort T
    Eur Neuropsychopharmacol; 2017 Apr; 27(4):399-410. PubMed ID: 28291572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomoxetine restores the response inhibition network in Parkinson's disease.
    Rae CL; Nombela C; Rodríguez PV; Ye Z; Hughes LE; Jones PS; Ham T; Rittman T; Coyle-Gilchrist I; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
    Brain; 2016 Aug; 139(Pt 8):2235-48. PubMed ID: 27343257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prefrontal Cortex Activation and Stopping Performance Underlie the Beneficial Effects of Atomoxetine on Response Inhibition in Healthy Volunteers and Those With Cocaine Use Disorder.
    Zhukovsky P; Morein-Zamir S; Ziauddeen H; Fernandez-Egea E; Meng C; Regenthal R; Sahakian BJ; Bullmore ET; Robbins TW; Dalley JW; Ersche KD
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Nov; 7(11):1116-1126. PubMed ID: 34508901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine-induced activation of caudate and anterior cingulate cortex in response to errors in schizophrenia.
    Moran LV; Stoeckel LE; Wang K; Caine CE; Villafuerte R; Calderon V; Baker JT; Ongur D; Janes AC; Evins AE; Pizzagalli DA
    Psychopharmacology (Berl); 2018 Mar; 235(3):789-802. PubMed ID: 29181816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nicotine on response inhibition and interference control.
    Ettinger U; Faiola E; Kasparbauer AM; Petrovsky N; Chan RC; Liepelt R; Kumari V
    Psychopharmacology (Berl); 2017 Apr; 234(7):1093-1111. PubMed ID: 28150023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks.
    Nandam LS; Hester R; Bellgrove MA
    Neuropsychologia; 2014 Apr; 56():263-70. PubMed ID: 24513025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease.
    O'Callaghan C; Hezemans FH; Ye R; Rua C; Jones PS; Murley AG; Holland N; Regenthal R; Tsvetanov KA; Wolpe N; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe JB
    Brain; 2021 Sep; 144(8):2513-2526. PubMed ID: 33783470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direction and magnitude of nicotine effects on the fMRI BOLD response are related to nicotine effects on behavioral performance.
    Warbrick T; Mobascher A; Brinkmeyer J; Musso F; Stoecker T; Shah NJ; Vossel S; Winterer G
    Psychopharmacology (Berl); 2011 May; 215(2):333-44. PubMed ID: 21243486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic receptor modulation of the default mode network.
    Hahn B; Harvey AN; Concheiro-Guisan M; Huestis MA; Ross TJ; Stein EA
    Psychopharmacology (Berl); 2021 Feb; 238(2):589-597. PubMed ID: 33216167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural correlates of atomoxetine improving inhibitory control and visual processing in Drug-naïve adults with attention-deficit/hyperactivity disorder.
    Fan LY; Chou TL; Gau SS
    Hum Brain Mapp; 2017 Oct; 38(10):4850-4864. PubMed ID: 28657141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Lin HY; Gau SS
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv094. PubMed ID: 26377368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia.
    Hong LE; Schroeder M; Ross TJ; Buchholz B; Salmeron BJ; Wonodi I; Thaker GK; Stein EA
    Schizophr Bull; 2011 Mar; 37(2):416-25. PubMed ID: 19713300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity.
    Potter AS; Bucci DJ; Newhouse PA
    Psychopharmacology (Berl); 2012 Mar; 220(2):331-40. PubMed ID: 21969123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study.
    Chou TL; Chia S; Shang CY; Gau SS
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2300-10. PubMed ID: 26409297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modulatory effects of nicotine on parietal cortex activity in a cued target detection task depend on cue reliability.
    Giessing C; Thiel CM; Rösler F; Fink GR
    Neuroscience; 2006 Feb; 137(3):853-64. PubMed ID: 16309846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.
    Chamberlain SR; Hampshire A; Müller U; Rubia K; Del Campo N; Craig K; Regenthal R; Suckling J; Roiser JP; Grant JE; Bullmore ET; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2009 Apr; 65(7):550-5. PubMed ID: 19026407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting impulsivity in Parkinson's disease using atomoxetine.
    Kehagia AA; Housden CR; Regenthal R; Barker RA; Müller U; Rowe J; Sahakian BJ; Robbins TW
    Brain; 2014 Jul; 137(Pt 7):1986-97. PubMed ID: 24893708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.